Preliminary study results suggest that the addition of immunotherapy to conventional chemotherapy may improve progression-free survival in patients with advanced bladder cancer. Is a paradigm shift on the horizon?
Preliminary study results suggest that the addition of immunotherapy to conventional chemotherapy may improve progression-free survival in patients with advanced bladder cancer. Is a paradigm shift on the horizon?
Input your search keywords and press Enter.